Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 418

1.

Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells.

Morgan MA, Canman CE.

Cancer Res. 2018 Dec 15;78(24):6713-6716. doi: 10.1158/0008-5472.CAN-18-2439. Epub 2018 Nov 29. Review.

PMID:
30498082
2.

Engineering CAR-T Cells for Improved Function Against Solid Tumors.

Morgan MA, Schambach A.

Front Immunol. 2018 Oct 29;9:2493. doi: 10.3389/fimmu.2018.02493. eCollection 2018. Review.

3.

TET2 coactivates gene expression through demethylation of enhancers.

Wang L, Ozark PA, Smith ER, Zhao Z, Marshall SA, Rendleman EJ, Piunti A, Ryan C, Whelan AL, Helmin KA, Morgan MA, Zou L, Singer BD, Shilatifard A.

Sci Adv. 2018 Nov 7;4(11):eaau6986. doi: 10.1126/sciadv.aau6986. eCollection 2018 Nov.

4.

A Guide to Midrotation Feedback.

Morgan MA, Jones LP.

J Am Coll Radiol. 2018 Oct 30. pii: S1546-1440(18)30995-5. doi: 10.1016/j.jacr.2018.08.004. [Epub ahead of print] No abstract available.

PMID:
30389331
5.

Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells.

Philipp F, Selich A, Rothe M, Hoffmann D, Rittinghausen S, Morgan MA, Klatt D, Glage S, Lienenklaus S, Neuhaus V, Sewald K, Braun A, Schambach A.

Stem Cell Reports. 2018 Nov 13;11(5):1051-1060. doi: 10.1016/j.stemcr.2018.09.010. Epub 2018 Oct 18.

6.

Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers.

Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, Hu X, Zhang Y, Wang Y, Jiang J, Li C, Zhong X, Montone KT, Guan G, Tanyi JL, Fan Y, Xu X, Morgan MA, Long M, Zhang Y, Zhang R, Sood AK, Rebbeck TR, Dang CV, Zhang L.

Cancer Cell. 2018 Oct 8;34(4):549-560.e9. doi: 10.1016/j.ccell.2018.08.019.

PMID:
30300578
7.

Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors.

Morgan MA, Schambach A.

Hum Gene Ther. 2018 Oct;29(10):1083-1097. doi: 10.1089/hum.2017.251. Epub 2018 Aug 29.

PMID:
30156435
8.

Pathology Consultation for the Gynecologic Oncologist: What the Surgeon Wants to Know.

Cory L, Morgan MA.

Arch Pathol Lab Med. 2018 Dec;142(12):1503-1508. doi: 10.5858/arpa.2018-0122-RA. Epub 2018 Aug 22.

PMID:
30133316
9.

Ureteral pseudodiverticulosis and urothelial cell carcinoma: rethinking the association.

Morgan MA, Chua WY, Zafar HM, Papanicolaou N, Ramchandani P.

Abdom Radiol (NY). 2018 Aug 4. doi: 10.1007/s00261-018-1726-6. [Epub ahead of print]

PMID:
30078084
10.

Metabolic Profiling of Chloroacetanilide Herbicides in Earthworm Coelomic Fluid Using 1H NMR and GC-MS.

Griffith CM, Morgan MA, Dinges MM, Mathon C, Larive CK.

J Proteome Res. 2018 Aug 3;17(8):2611-2622. doi: 10.1021/acs.jproteome.8b00081. Epub 2018 Jul 16.

PMID:
29939029
11.

The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.

Parsels LA, Parsels JD, Tanska DM, Maybaum J, Lawrence TS, Morgan MA.

Cell Cycle. 2018;17(9):1076-1086. doi: 10.1080/15384101.2018.1475827. Epub 2018 Jul 18.

PMID:
29895190
12.

Epigenetic ConFUSION: SS18-SSX Fusion Rewires BAF Complex to Activate Bivalent Genes in Synovial Sarcoma.

Morgan MA, Shilatifard A.

Cancer Cell. 2018 Jun 11;33(6):951-953. doi: 10.1016/j.ccell.2018.05.011.

PMID:
29894696
13.

Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.

Wang L, Zhao Z, Ozark PA, Fantini D, Marshall SA, Rendleman EJ, Cozzolino KA, Louis N, He X, Morgan MA, Takahashi YH, Collings CK, Smith ER, Ntziachristos P, Savas JN, Zou L, Hashizume R, Meeks JJ, Shilatifard A.

Nat Med. 2018 Jun;24(6):758-769. doi: 10.1038/s41591-018-0034-6. Epub 2018 May 21.

14.

Multiplexed precision genome editing with trackable genomic barcodes in yeast.

Roy KR, Smith JD, Vonesch SC, Lin G, Tu CS, Lederer AR, Chu A, Suresh S, Nguyen M, Horecka J, Tripathi A, Burnett WT, Morgan MA, Schulz J, Orsley KM, Wei W, Aiyar RS, Davis RW, Bankaitis VA, Haber JE, Salit ML, St Onge RP, Steinmetz LM.

Nat Biotechnol. 2018 Jul;36(6):512-520. doi: 10.1038/nbt.4137. Epub 2018 May 7.

15.

Voiding cystourethrography after prostatectomy: spectrum of appearances.

Morgan MA, Papanicolaou N.

Abdom Radiol (NY). 2018 Nov;43(11):3060-3067. doi: 10.1007/s00261-018-1564-6. Review.

PMID:
29556701
16.

Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.

Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, Ganetsky A, Morgan MA, Gill S, Tanyi JL, Bushman FD, June CH, Facciabene A.

JCI Insight. 2018 Feb 22;3(4). pii: 94952. doi: 10.1172/jci.insight.94952. [Epub ahead of print]

17.

An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells.

Cao K, Collings CK, Morgan MA, Marshall SA, Rendleman EJ, Ozark PA, Smith ER, Shilatifard A.

Sci Adv. 2018 Jan 31;4(1):eaap8747. doi: 10.1126/sciadv.aap8747. eCollection 2018 Jan.

18.

Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency.

Shapiro BB MD, MPH, Hedrick R, Vanle BC, Becker CA, Nguyen C, Underhill DM, Morgan MA, Kopple JD, Danovitch I, IsHak WW.

BMJ Case Rep. 2018 Jan 26;2018. pii: bcr-2017-221435. doi: 10.1136/bcr-2017-221435.

PMID:
29374632
19.

Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01329-17. doi: 10.1128/JCM.01329-17. Print 2018 Apr.

20.

Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy.

Cuneo KC, Morgan MA, Griffith KA, Hawkins PG, Greenson JK, Ben-Josef E, Lawrence TS, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):490-497. doi: 10.1016/j.ijrobp.2017.10.030. Epub 2017 Oct 28.

PMID:
29229329
21.

Long-lived unipotent Blimp1-positive luminal stem cells drive mammary gland organogenesis throughout adult life.

Elias S, Morgan MA, Bikoff EK, Robertson EJ.

Nat Commun. 2017 Nov 20;8(1):1714. doi: 10.1038/s41467-017-01971-w.

22.

PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.

Parsels LA, Karnak D, Parsels JD, Zhang Q, Vélez-Padilla J, Reichert ZR, Wahl DR, Maybaum J, O'Connor MJ, Lawrence TS, Morgan MA.

Mol Cancer Res. 2018 Feb;16(2):222-232. doi: 10.1158/1541-7786.MCR-17-0455. Epub 2017 Nov 13.

PMID:
29133592
23.

The Future of Radiobiology.

Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ.

J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. doi: 10.1093/jnci/djx231.

24.

Uncoupling the Oncogenic Engine.

Schambach A, Schott JW, Morgan MA.

Cancer Res. 2017 Nov 15;77(22):6060-6064. doi: 10.1158/0008-5472.CAN-17-2362. Epub 2017 Nov 2. Review.

25.

A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation.

Morgan MAJ, Rickels RA, Collings CK, He X, Cao K, Herz HM, Cozzolino KA, Abshiru NA, Marshall SA, Rendleman EJ, Sze CC, Piunti A, Kelleher NL, Savas JN, Shilatifard A.

Genes Dev. 2017 Oct 1;31(19):2003-2014. doi: 10.1101/gad.305201.117.

26.

Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.

Roberson PL, Smith LB, Morgan MA, Schipper MJ, Wilderman SJ, Avram AM, Kaminski MS, Dewaraja YK.

Cancer Biother Radiopharm. 2017 Nov;32(9):309-319. doi: 10.1089/cbr.2017.2182. Epub 2017 Oct 30.

27.

Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.

Rickels R, Herz HM, Sze CC, Cao K, Morgan MA, Collings CK, Gause M, Takahashi YH, Wang L, Rendleman EJ, Marshall SA, Krueger A, Bartom ET, Piunti A, Smith ER, Abshiru NA, Kelleher NL, Dorsett D, Shilatifard A.

Nat Genet. 2017 Nov;49(11):1647-1653. doi: 10.1038/ng.3965. Epub 2017 Oct 2.

28.

Histone H3K4 methylation-dependent and -independent functions of Set1A/COMPASS in embryonic stem cell self-renewal and differentiation.

Sze CC, Cao K, Collings CK, Marshall SA, Rendleman EJ, Ozark PA, Chen FX, Morgan MA, Wang L, Shilatifard A.

Genes Dev. 2017 Sep 1;31(17):1732-1737. doi: 10.1101/gad.303768.117. Epub 2017 Sep 22.

29.

Continent versus incontinent diversion for obstetric fistula.

Morgan MA.

BJOG. 2018 Apr;125(5):623. doi: 10.1111/1471-0528.14772. Epub 2017 Jul 17. No abstract available.

PMID:
28658528
30.

Improving Self-Efficacy and Self-Care in Adult Patients With a Urinary Diversion: A Pilot Study.

Merandy K, Morgan MA, Lee R, Scherr DS.

Oncol Nurs Forum. 2017 May 1;44(3):E90-E100. doi: 10.1188/17.ONF.E90-E100.

31.

Exercise Among Women With Ovarian Cancer: A Feasibility and Pre-/Post-Test Exploratory Pilot Study.

Zhang X, McClean D, Ko E, Morgan MA, Schmitz K.

Oncol Nurs Forum. 2017 May 1;44(3):366-374. doi: 10.1188/17.ONF.366-374.

PMID:
28635971
32.

SET1A/COMPASS and shadow enhancers in the regulation of homeotic gene expression.

Cao K, Collings CK, Marshall SA, Morgan MA, Rendleman EJ, Wang L, Sze CC, Sun T, Bartom ET, Shilatifard A.

Genes Dev. 2017 Apr 15;31(8):787-801. doi: 10.1101/gad.294744.116. Epub 2017 May 9.

33.

Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.

Vo BT, Li C, Morgan MA, Theurillat I, Finkelstein D, Wright S, Hyle J, Smith SMC, Fan Y, Wang YD, Wu G, Orr BA, Northcott PA, Shilatifard A, Sherr CJ, Roussel MF.

Cell Rep. 2017 Mar 21;18(12):2907-2917. doi: 10.1016/j.celrep.2017.02.073.

34.

Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.

Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA, Rendleman EJ, Ma Q, Takahashi YH, Woodfin AR, Misharin AV, Abshiru NA, Lulla RR, Saratsis AM, Kelleher NL, James CD, Shilatifard A.

Nat Med. 2017 Apr;23(4):493-500. doi: 10.1038/nm.4296. Epub 2017 Feb 27.

35.

Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy.

An M, Lohse I, Tan Z, Zhu J, Wu J, Kurapati H, Morgan MA, Lawrence TS, Cuneo KC, Lubman DM.

J Proteome Res. 2017 Apr 7;16(4):1763-1772. doi: 10.1021/acs.jproteome.7b00024. Epub 2017 Mar 8.

36.

Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells.

Tanyi JL, Stashwick C, Plesa G, Morgan MA, Porter D, Maus MV, June CH.

J Immunother. 2017 Apr;40(3):104-107. doi: 10.1097/CJI.0000000000000160.

PMID:
28234665
37.

Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification.

Hu D, Gao X, Cao K, Morgan MA, Mas G, Smith ER, Volk AG, Bartom ET, Crispino JD, Di Croce L, Shilatifard A.

Mol Cell. 2017 Feb 2;65(3):460-475.e6. doi: 10.1016/j.molcel.2017.01.013.

38.

Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis.

Wahl DR, Dresser J, Wilder-Romans K, Parsels JD, Zhao SG, Davis M, Zhao L, Kachman M, Wernisch S, Burant CF, Morgan MA, Feng FY, Speers C, Lyssiotis CA, Lawrence TS.

Cancer Res. 2017 Feb 15;77(4):960-970. doi: 10.1158/0008-5472.CAN-16-2008. Epub 2016 Dec 6.

39.

Bioavailable estradiol concentrations are elevated and predict mortality in septic patients: a prospective cohort study.

Tsang G, Insel MB, Weis JM, Morgan MA, Gough MS, Frasier LM, Mack CM, Doolin KP, Graves BT, Apostolakos MJ, Pietropaoli AP.

Crit Care. 2016 Oct 21;20(1):335.

40.

Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation.

Zhang Q, Zhang Y, Parsels JD, Lohse I, Lawrence TS, Pasca di Magliano M, Sun Y, Morgan MA.

Neoplasia. 2016 Nov;18(11):666-673. doi: 10.1016/j.neo.2016.08.009. Epub 2016 Oct 18.

41.

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Rose PG, Java JJ, Morgan MA, Alvarez-Secord A, Kesterson JP, Stehman FB, Warshal DP, Creasman WT, Hanjani P, Morris RT, Copeland LJ.

Gynecol Oncol. 2016 Dec;143(3):511-515. doi: 10.1016/j.ygyno.2016.09.005. Epub 2016 Sep 28.

42.

Whole gut microbiome composition of damselfish and cardinalfish before and after reef settlement.

Parris DJ, Brooker RM, Morgan MA, Dixson DL, Stewart FJ.

PeerJ. 2016 Aug 31;4:e2412. doi: 10.7717/peerj.2412. eCollection 2016.

43.

Translation of Targeted Radiation Sensitizers into Clinical Trials.

Reichert ZR, Wahl DR, Morgan MA.

Semin Radiat Oncol. 2016 Oct;26(4):261-70. doi: 10.1016/j.semradonc.2016.06.001. Epub 2016 Jun 2. Review.

PMID:
27619248
44.

Methionine Metabolites in Patients With Sepsis.

Wexler O, Gough MS, Morgan MAM, Mack CM, Apostolakos MJ, Doolin KP, Mooney RA, Arning E, Bottiglieri T, Pietropaoli AP.

J Intensive Care Med. 2018 Jan;33(1):37-47. doi: 10.1177/0885066616666002. Epub 2016 Sep 2.

PMID:
27591199
45.

Reply.

Shalowitz DI, Spillman MA, Morgan MA.

Am J Obstet Gynecol. 2016 Dec;215(6):811. doi: 10.1016/j.ajog.2016.07.054. Epub 2016 Aug 2. No abstract available.

PMID:
27496688
46.

NCCN Guidelines Insights: Survivorship, Version 1.2016.

Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 Jun;14(6):715-24.

47.

Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress.

Cuneo KC, Morgan MA, Davis MA, Parcels LA, Parcels J, Karnak D, Ryan C, Liu N, Maybaum J, Lawrence TS.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):782-90. doi: 10.1016/j.ijrobp.2016.01.028. Epub 2016 Jan 22.

PMID:
26975930
48.

Interactions with industry under the Sunshine Act: an example from gynecologic oncology.

Shalowitz DI, Spillman MA, Morgan MA.

Am J Obstet Gynecol. 2016 Jun;214(6):703-7. doi: 10.1016/j.ajog.2016.02.035. Epub 2016 Feb 20.

PMID:
26902988
49.

Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry.

Parsels LA, Tanska DM, Parsels JD, Zabludoff SD, Cuneo KC, Lawrence TS, Maybaum J, Morgan MA.

Cell Cycle. 2016;15(5):730-9. doi: 10.1080/15384101.2016.1148841.

50.

FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.

Zhang Q, Karnak D, Tan M, Lawrence TS, Morgan MA, Sun Y.

Mol Cell. 2016 Feb 4;61(3):419-433. doi: 10.1016/j.molcel.2015.12.010. Epub 2016 Jan 7.

Supplemental Content

Loading ...
Support Center